Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 30/04/2025

72,00 USD (+0,84%)

(+0,84%) 30/04/2025

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d 0,84%
1 week1w 4,41%
1 maand1m 0,00%
3 maanden3m -7,55%
6 maanden6m 5,39%
1 jaar1j 181,36%
5 jaar5j 221,14%

donderdag 8 mei 2025, 13:00

Kwartaalcijfers (1ste kwartaal)

Insmed Inc in het nieuws

Toon enkel gratis nieuws

29 april 2025 · Insmed To Present at the BofA Securities 2025 Health Care Conference · Persbericht

24 april 2025 · Insmed Announces Redemption of all $569.5 Million of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028 · Persbericht

23 april 2025 · New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis · Persbericht

23 april 2025 · Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025 · Persbericht

25 maart 2025 · Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference · Persbericht

10 maart 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

6 september 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

8 augustus 2024 · Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update · Persbericht

2 augustus 2024 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

29 juli 2024 · Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024 · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

CEO: William Lewis

Werknemers: 778

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe